Ânima Profit Triples to US$5.6 Million in Q2 2026 on Fatter Margins
Ânima reported net income tripled to R$29.1 million (US$5.6M) in Q2 2026, but the leap flatters a weak base; adjusted profit was flat as revenue rose 4.4%.
Brazil · Earnings
Key Facts
- —The profit Ânima booked reported net income of R$29.1 million (about US$5.6 million) in Q2 2026, more than triple the R$9.5 million of a year earlier.
- —The base effect That R$9.5 million was a depressed figure; on an adjusted basis, Ânima already earned R$29.2 million in Q2 2025, so underlying profit was roughly flat.
- —The revenue Net revenue rose 4.4% to R$1.05 billion (around US$202 million), a modest gain well behind the headline profit leap.
- —The engine Adjusted EBITDA climbed 9.0% to R$383.8 million (about US$74 million), and the margin widened 1.6 points to 36.6%.
- —The driver Higher tuition, tighter costs and the high-margin Inspirali medical arm lifted margins, while lower financial expenses helped the bottom line.
The jump looks dramatic, but it leans on a weak year-earlier base. Strip out one-offs and profit barely moved as revenue grew just 4.4%.
Ânima Educação, one of Brazil’s largest higher-education groups, said its reported profit more than tripled in the second quarter of 2026. The catch is that the leap flatters a weak year-earlier number.
And the real story is steady margins rather than a sudden windfall.
What Ânima actually reported
The company posted reported net income of R$29.1 million, or about US$5.6 million, for the April-to-June quarter. That was more than three times the R$9.5 million it booked in the same period a year earlier.
Ânima trades on Brazil’s B3 exchange under the ticker ANIM3. It runs a network of universities and, through its Inspirali arm, one of the country’s biggest groups of medical schools.
Why the tripling looks bigger than it is
The headline is technically true, but it rests on a small base. In Q2 2025 the reported figure was held down to just R$9.5 million by accounting charges.
Strip those out and the picture changes. On an adjusted basis, the group already earned R$29.2 million a year earlier, so underlying profit this quarter was essentially flat.
The small base, explained
Brazilian companies often report two profit lines. One is the raw accounting number, and the other strips out non-cash items like goodwill amortization and one-off costs.
Because those charges hit Q2 2025 hard, the raw number that year looked tiny next to the adjusted one. As a result, this year’s ordinary profit produces an eye-catching multiple against it.
Revenue rose, but slowly
Net revenue grew 4.4% to R$1.05 billion, or around US$202 million. That is solid, yet far short of the profit jump the headline suggests.
In other words, the business is expanding at a steady clip rather than surging. The gap between 4.4% revenue growth and a tripled profit line is the clearest sign the base did the work.
Margins did the heavy lifting
The real progress showed up in profitability. Adjusted EBITDA, a gauge of core operating cash, rose 9.0% to R$383.8 million, roughly US$74 million.
Crucially, EBITDA grew faster than revenue. So the margin on that measure widened by 1.6 percentage points to 36.6%.
Meaning the group kept more of every real it took in.
Medicine keeps carrying the group
Much of that margin strength traces back to medicine. The Inspirali arm, which runs Ânima’s medical schools, remains the most profitable slice of the business.
Medical tuition rose about 6.5% in the quarter, and demand for the seats stays firm. Meanwhile, higher average tickets across the group helped offset a shrinking student headcount.
Fewer students, higher tuition
The growth did not come from packing in more students. In fact, the total base shrank, pressured by higher drop-out rates in its classroom and digital courses.
Instead, the company leaned on price. Tuition rose across the board, up 7.4% in core courses.
4.2% in digital and 6.5% in medicine, which lifted revenue even as enrollment slipped.
Lower financing costs helped too
The bottom line also got a lift from cheaper debt. Ânima has spent recent quarters trimming its borrowings, which carried heavy interest charges through 2025.
As those financial expenses ease, more of the operating profit survives to the net line. That is why a modest gain in operations translated into a much larger reported profit.
How to read the quarter
For anyone glancing at the headline, the takeaway is simple but easy to misread. Yes, reported profit tripled, yet the underlying business improved only modestly.
Still, the direction is encouraging. Margins are widening, medicine is resilient, and lighter debt costs are feeding through.
Even if the dramatic multiple owes more to last year’s weak base.
Frequently Asked Questions
How much did Ânima profit rise in Q2 2026?
Ânima reported net income of R$29.1 million, about US$5.6 million, more than triple the R$9.5 million of a year earlier. But that base was unusually low, and on an adjusted basis the group had already earned R$29.2 million in Q2 2025.
Is the tripling of profit real?
It is real on a reported, accounting basis, but the eye-catching multiple mostly reflects a weak year-earlier figure. That R$9.5 million was depressed by goodwill amortization and one-off charges.
What drove the improvement?
Wider margins, higher tuition and lower financing costs. Adjusted EBITDA rose 9.0% to R$383.8 million and the margin widened to 36.6%.
How can I follow Ânima shares?
Ânima Educação trades on Brazil’s B3 exchange under the ticker ANIM3. Investors are watching medicine demand.
Connected Coverage
Sources: InfoMoney; SpaceMoney; Reuters; Neofeed; Ânima Investor Relations.
This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error